|
US 11,702,409 B2 |
|
| Pyrazolyl derivatives useful as anti-cancer agents |
| Simona Cotesta, Basel (CH); Marc Gerspacher, Hägendorf (CH); Catherine Leblanc, Basel (CH); Edwige Liliane Jeanne Lorthiois, Niffer (FR); Bo Liu, Shanghai (CN); Rainer Machauer, Freiburg (DE); Robert Mah, Muenchenstein (CH); Christophe Mura, Rosenau (FR); Pascal Rigollier, Hagenthal-le-Bas (FR); Nadine Schneider, Basel (CH); Stefan Stutz, Basel (CH); Andrea Vaupel, Riehen (CH); Nicolas Warin, Basel (CH); and Rainer Wilcken, Basel (CH) |
| Assigned to NOVARTIS AG, Basel (CH) |
| Filed by NOVARTIS AG, Basel (CH) |
| Filed on Dec. 17, 2020, as Appl. No. 17/125,335. |
| Claims priority of provisional application 62/951,400, filed on Dec. 20, 2019. |
| Claims priority of application No. PCT/CN2020/125425 (WO), filed on Oct. 30, 2020. |
| Prior Publication US 2022/0363670 A1, Nov. 17, 2022 |
| Int. Cl. C07D 403/14 (2006.01); C07D 401/14 (2006.01); C07D 405/14 (2006.01); C07D 413/14 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01) |
